TheraRNA

Nanjing, China · Founded 2019 · Privately Held (backing)

Manufacturer of mRNA vaccine drugs designed to treat infectious diseases and cancers. TheraRNA is based in Nanjing, China and was founded in 2019. Its last reported valuation was $27.9 million in Dec 2022. It has raised $6.4 million.

Last reported valuation

$27.9M

Oct 2026

Priced at

—

Total raised

$6.4M

Last round

—

How much has TheraRNA raised?

$6.4Macross 0 recorded rounds

Free account

More of TheraRNA with a free account

·Watch TheraRNA: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

TheraRNA investors

4 investors are on record for TheraRNA, including Oriental Fortune Capital, Shenzhen Weltrust Investment Co., CrowdBees and Share Capital.

For fundraisers

Raising for a company like TheraRNA?

4 investors have backed TheraRNA.

See all 4 investors →

Frequently asked about TheraRNA

How much has TheraRNA raised?: TheraRNA has raised $6.4M in total across 0 recorded funding rounds.